DRI Healthcare Trust Reports Record Q1 Income and Expanded Margins
DRI Healthcare Trust reported first-quarter income of $50.6 million, up 15% year over year, driven by cost synergies from internalization and strong performance across several portfolio assets like EMPAVELI, ORSERDU, XENPOZYME, and XOLAIR. Despite a decline in cash receipts due to one-time payments and weaker performances from some products, the company maintained its quarterly distribution of $0.11 per unit.
Tickers: $MCD
Topics: adjusted EBITDA margin balance sheet strength financial performance royalty income